Sonja Blasche

Sonja Blasche

Auto-generated profile, based on publicly available information

Sonja Blasche

MRC Toxicology Unit, University of Cambridge, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Science
Verified
Journal Article
Open access
EGEvangelos Giampazolias
Evangelos Giampazolias
MCMariana Pereira da Costa
Mariana Pereira da Costa
KLKhiem C. Lam
Khiem C. Lam
KLKok Haw Jonathan Lim
Kok Haw Jonathan Lim
ACAna Cardoso
Ana Cardoso
CSCaetano Reis e Sousa
Caetano Reis e Sousa
A role for vitamin D in immune modulation and in cancer has been suggested. In this work, we report that mice with increased availability of vitamin D display greater immune-dependent resistance to transplantable cancers and augmented responses to checkpoint blockade immunotherapies. Similarly, in humans, vitamin D–induced genes correlate with improved responses to immune checkpoint inhibitor treatment as well as with immunity to cancer and increased overall survival. In mice, resistance is attributable to the activity of vitamin D on intestinal epithelial cells, which alters microbiome composition in favor of Bacteroides fragilis , which positively regulates cancer immunity. Our findings indicate a previously unappreciated connection between vitamin D, microbial commensal communities, and immune responses to cancer. Collectively, they highlight vitamin D levels as a potential determinant of cancer immunity and immunotherapy success.

13 December 2023 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
PMPatrick Müller
Patrick Müller
JCJuan Jacobo De la Cuesta-Zuluaga
Juan Jacobo De la Cuesta-Zuluaga
MKMichael Kuhn
Michael Kuhn
MAMaral Baghai Arassi
Maral Baghai Arassi
TTTim Treis
Tim Treis
LMLisa Maier
Lisa Maier

5 February 2024 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
RBRebecca H Boston
Rebecca H Boston
RGRui Guan
Rui Guan
LKLajos Kalmar
Lajos Kalmar
SBSina Beier
Sina Beier
EHEmily C Horner
Emily C Horner
KPKiran R Patil
Kiran R Patil
Bidirectional interactions between the immune system and the gut microbiota are key contributors to various physiological functions. Immune-associated diseases such as cancer and autoimmunity, and efficacy of immunomodulatory therapies, have been linked to microbiome variation. Although COVID-19 infection has been shown to cause microbial dysbiosis, it remains understudied whether the inflammatory response associated with vaccination also impacts the microbiota. Here, we investigate the temporal impact of COVID-19 vaccination on the gut microbiome in healthy and immuno-compromised individuals; the latter included patients with primary immunodeficiency and cancer patients on immunomodulating therapies. We find that the gut microbiome remained remarkably stable post-vaccination irrespective of diverse immune status, vaccine response, and microbial composition spanned by the cohort. The stability is evident at all evaluated levels including diversity, phylum, species, and functional capacity. Our results indicate the resilience of the gut microbiome to host immune changes triggered by COVID-19 vaccination and suggest minimal, if any, impact on microbiome-mediated processes. These findings encourage vaccine acceptance, particularly when contrasted with the significant microbiome shifts observed during COVID-19 infection.

31 March 2026 in Nature Ecology & Evolution
Verified
Journal Article
Open access
SKStephan Kamrad
Stephan Kamrad
SASimran K. Aulakh
Simran K. Aulakh
SMSimone Mozzachiodi
Simone Mozzachiodi
SBSonja Blasche
Sonja Blasche
DSDavid Scheidweiler
David Scheidweiler
KPKiran R. Patil
Kiran R. Patil
Species in microbial communities need to stave off competition and capitalize on new resources that become available because of metabolic activities of others. However, intra-cellular molecular changes that underpin these responses are understudied, preventing mechanistic insights into community function and dynamics. Here we analyse proteomic and metabolomic responses in 104 pairwise co-cultures of 15 gut bacteria, spanning a diversity of ecological interactions from competition to mutualism. We find that molecular responses to co-culturing are substantial, with typically 50% of the quantified proteome changing in at least one co-culture, jointly influenced by genome size, species abundance and pH. Even closely related species and orthologue proteins show different expression profiles in response to the same partner, indicating functional diversification at both protein and species level. Small-molecule transport and carbon metabolism are among the most responsive processes, indicating pervasive metabolic interactions. Using metabolomics, we identify likely cross-fed metabolites, emergent polyamine metabolism and niche partitioning in amino acid utilization. Overall, our study uncovers how bacteria respond to the presence of other species through extensive remodelling of their proteome and metabolome.

29 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNaomi Iris van Den Berg
Naomi Iris van Den Berg
MTMelanie Tramontano
Melanie Tramontano
RGRui Guan
Rui Guan
SASergej Andrejev
Sergej Andrejev
SBSonja Blasche
Sonja Blasche
KPKiran R. Patil
Kiran R. Patil
Synthetic communities can help uncover metabolic forces shaping microbial ecosystems. Yet, in case of the gut microbiota, culturing in undefined media has prevented detection of metabolic dependencies. Here we show, using chemically defined media, how species survival is jointly determined by supplied resources and community metabolism. We used 63 representative gut bacterial strains and varied inoculum compositions to assemble stable communities in 14 defined media. Over 95% of the species showed markedly improved or diminished performance relative to monoculture in at least one condition, including 153 cases (21%) of emergent survival, i.e., species incapable of surviving on their own but thriving in a community, and 252 (35%) community-driven extinctions. Through single species additions and exclusions, metabolomic analysis, and ecological modelling, we demonstrate how inter-species dependencies – especially in poor media – are mediated by biotic nutrient supply. Our results highlight communal metabolic dividend as a key biotic force promoting emergent survival and diversity.

9 March 2026 in Current Opinion in Biotechnology
Verified
Journal Article
Open access
SBSonja Blasche
Sonja Blasche
SMSimone Mozzachiodi
Simone Mozzachiodi
IRIndra Roux
Indra Roux
KPKiran R Patil
Kiran R Patil
Microbiology research is expanding from model species to non-model species and from studying single-species phenotypes to microbiomes and emergent functions. Here, we review the biotechnological opportunities brought forward by this expansion. Omics and automation have expanded the catalogue of non-model microbes that can be used in biotechnology, either on their own or as modules for assembling synthetic communities. The latter offer a complementary or alternative approach to monocultures due to their high resilience, single-step processing of complex substrates and suitability for open-environment applications. We also review the tools for engineering model and non-model microorganisms and communities, namely, targeted genome editing, adaptive laboratory evolution and ecological engineering. Going forward, increased focus on non-model microbes and methods for designing synthetic communities is needed to unlock the potential of the rich functional repertoire of non-model organisms and microbial communities.